Preliminary research reveal conolidine may perhaps inhibit certain ion channels, lessening neuronal excitability and limiting suffering signals. This mechanism is particularly appropriate in neuropathic suffering, in which abnormal signaling leads to persistent discomfort. Also, conolidine appears to affect G protein-coupled receptor (GPCR) pathway